Upscheduling hits margins despite sales surge for alternatives
Pharmacy margins have taken a hit since codeine upscheduling, despite a corresponding surge in sales of other pharmacy-only analgesics.
That’s according to data compiled by Advantage Pharmacy CEO Steven Kastrinakis.
He says that during February, pharmacies lost around 20% of their margin for the pain category,
The dip was due to an 87% drop in sales of low-dose codeine in February compared with the same time last year.
These products used to account for around one-quarter of all sales in the analgesics category.
Sales of combined